Host range and cellular tropism of the human exogenous gammaretrovirus XMRV

Virology

Volumn 399, Issue 1, 2010, Pages 23-30

  Stieler, Kristin ^a   Schulz, Claudia ^a   Lavanya, Madakasira ^b   Aepfelbacher, Martin ^a   Stocking, Carol ^c   Fischer, Nicole ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

Host range; Human gammaretrovirus; LTR activity; Receptor studies; XMRV; XPR1

Indexed keywords

PHOSPHATE TRANSPORTER; PROTEIN XPR1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; HEMATOPOIETIC CELL; HOST RANGE; HUMAN; HUMAN CELL; IN VIVO STUDY; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROVIRUS; TISSUE DISTRIBUTION; VIROGENESIS; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CELL LINE; CELL MEMBRANE; GAMMARETROVIRUS; HUMANS; MALE; MICE; PHYLOGENY; PROSTATE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VIRUS; RETROVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TERMINAL REPEAT SEQUENCES; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

GAMMARETROVIRUS;

EID: 77049083357     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.12.028     Document Type: Article

References (30)

1. Barnett A.L., Wensel D.L., Li W., Fass D., and Cunningham J.M. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J. Virol. 77 4 (2003) 2717-2729
2. Battini J.L., Danos O., and Heard J.M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69 2 (1995) 713-719
3. Battini J.L., Rasko J.E., and Miller A.D. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc. Natl. Acad. Sci. U.S.A. 96 4 (1999) 1385-1390
4. Battini J.L., Rodrigues P., Muller R., Danos O., and Heard J.M. Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J. Virol. 70 7 (1996) 4387-4393
5. Beyer W.R., Westphal M., Ostertag W., and von Laer D. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J. Virol. 76 3 (2002) 1488-1495
6. Dong B., Kim S., Hong S., Das Gupta J., Malathi K., Klein E.A., Ganem D., Derisi J.L., Chow S.A., and Silverman R.H. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. U.S.A. 104 5 (2007) 1655-1660
7. Fass D., Davey R.A., Hamson C.A., Kim P.S., Cunningham J.M., and Berger J.M. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277 5332 (1997) 1662-1666
8. Fischer N., Hellwinkel O., Schulz C., Chun F.K., Huland H., Aepfelbacher M., and Schlomm T. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J. Clin. Virol. 43 3 (2008) 277-283
9. Gerdes M.J., Dang T.D., Lu B., Larsen M., McBride L., and Rowley D.R. Androgen-regulated proliferation and gene transcription in a prostate smooth muscle cell line (PS-1). Endocrinology 137 3 (1996) 864-872
10. Ghez D., Lepelletier Y., Lambert S., Fourneau J.M., Blot V., Janvier S., Arnulf B., van Endert P.M., Heveker N., Pique C., and Hermine O. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80 14 (2006) 6844-6854
11. Heard J.M., and Danos O. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65 8 (1991) 4026-4032
12. Hohn O., Krause H., Barbarotto P., Niederstadt L., Beimforde N., Denner J., Miller K., Kurth R., and Bannert N. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6 (2009) 92
13. Hong S., Klein E.A., Das Gupta J., Hanke K., Weight C.J., Nguyen C., Gaughan C., Kim K.A., Bannert N., Kirchhoff F., Munch J., and Silverman R.H. Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J. Virol. 83 14 (2009) 6995-7003
14. + T cells. J. Virol. 79 20 (2005) 12692-12702
15. Kim F.J., Manel N., Garrido E.N., Valle C., Sitbon M., and Battini J.L. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology 1 (2004) 41
16. Knouf E.C., Metzger M.J., Mitchell P.S., Arroyo J.D., Chevillet J.R., Tewari M., and Miller A.D. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J. Virol. 83 14 (2009) 7353-7356
17. Lavanya M., Kinet S., Montel-Hagen A., Mongellaz C., Battini J.L., Sitbon M., and Taylor N. Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement. J. Immunol. 181 2 (2008) 891-898
18. Lombardi V.C., Ruscetti F.W., Das Gupta J., Pfost M.A., Hagen K.S., Peterson D.L., Ruscetti S.K., Bagni R.K., Petrow-Sadowski C., Gold B., Dean M., Silverman R.H., and Mikovits J.A. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326 5952 (2009) 585-589
19. Miller A.D., and Chen F. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 70 8 (1996) 5564-5571
20. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 12 (2000) 1063-1066
21. Ott D., Friedrich R., and Rein A. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J. Virol. 64 2 (1990) 757-766
22. Pinon J.D., Klasse P.J., Jassal S.R., Welson S., Weber J., Brighty D.W., and Sattentau Q.J. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J. Virol. 77 18 (2003) 9922-9930
23. Schlaberg R., Choe D.J., Brown K.R., Thaker H.M., and Singh I.R. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc. Natl. Acad. Sci. U.S.A. 106 38 (2009) 16351-16356
24. Schwieger M., Lohler J., Friel J., Scheller M., Horak I., and Stocking C. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J. Exp. Med. 196 9 (2002) 1227-1240
25. Tailor C.S., Willett B.J., and Kabat D. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J. Virol. 73 8 (1999) 6500-6505
26. Tuxhorn J.A., McAlhany S.J., Dang T.D., Ayala G.E., and Rowley D.R. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 62 11 (2002) 3298-3307
27. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., Malathi K., Magi-Galluzzi C., Tubbs R.R., Ganem D., Silverman R.H., and DeRisi J.L. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2 3 (2006) e25
28. Yan Y., Liu Q., and Kozak C.A. Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology 6 (2009) 87
29. Yang Y.L., Guo L., Xu S., Holland C.A., Kitamura T., Hunter K., and Cunningham J.M. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat. Genet. 21 2 (1999) 216-219
30. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., and Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91 20 (1994) 9564-9568